Diversity, More Advocacy Among Lobo’s Top Priorities As New AdvaMed Board Chair
Executive Summary
Stryker CEO Kevin Lobo says while repeal of the medical device tax is his top issue, there are four main priorities he wants to work on over the next two years as industry advocate group AdvaMed’s board chair. They include better public engagement, increased advocacy work with the new Congress, advancing new technology – especially start-ups – and increasing diversity in the medtech industry.
You may also be interested in...
New AdvaMed Board Chair To Make Military Veteran Recruitment A Priority
A former Army ranger, Michael Minogue wants to help military veterans transition into and gain employment opportunities in the medtech industry.
AdvaMed Throws Weight Behind Protestors In Ongoing US Demonstrations
AdvaMed CEO Scott Whitaker shared a letter he sent to member companies voicing support for the ongoing protests around the US against police brutality that were sparked after the killing of George Floyd. “While we continue our single-minded pursuit of medical breakthroughs to treat and cure disease, we must also have a single-minded focus on eradicating the disease of racism in this country and around the world,” Whitaker wrote.
After AdvaMed, Yared Takes Helm Of MDIC Board
CVRx CEO Nadim Yared has moved up on the board of directors at the Medical Device Innovation Consortium as its new chair. The public-private partnership group that formed in 2012 has been effective in working with the US Food and Drug Administration to develop new regulations.